Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
ICC Labs Inc.

Start price
Target price
Perf. (%)
€0.91
22.02.18
€1.60
22.08.18
4.70%
22.08.18

Bernhardow 
22.02.18 50%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€27.73
25.06.18
€35.00
15.08.18
-4.00%
15.08.18

Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Known brand
gerihouse 
02.08.19 50%
buy
InMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€429.00
11.07.18
€825.00
14.08.18
-14.04%
14.08.18

piccolo90 
18.08.19 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€9.25
06.02.18
€22.80
06.08.18
-25.08%
06.08.18

melinda 
18.08.19 50%
buy
AEterna Zentaris Inc.

Start price
Target price
Perf. (%)
€49.30
01.02.18
€85.69
01.08.18
-18.59%
01.08.18

melinda 
18.08.19 50%
buy
InMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€427.35
10.07.18
€825.00
25.07.18
-12.74%
25.07.18

Traumtanz 
05.08.19 50%
buy
MicroPlanet Technology Corp

Start price
Target price
Perf. (%)
€5.63
17.07.17
€12.00
17.07.18
-22.61%
17.07.18

sebbo 
20.08.19 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€8.28
24.06.18
€15.00
28.06.18
-8.57%
28.06.18

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Traumtanz 
05.08.19 50%
buy
ICC Labs Inc.

Start price
Target price
Perf. (%)
€0.59
14.12.17
€1.33
14.06.18
68.14%
14.06.18

piccolo90 
18.08.19 50%
buy
Bausch Health Companies Inc.

Start price
Target price
Perf. (%)
€20.77
03.01.18
€23.45
07.06.18
8.16%
07.06.18

melinda 
18.08.19 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€7.75
28.11.17
€26.00
07.06.18
-0.13%
07.06.18

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Maxi_Scalibusa 
15.08.19 50%
buy
Emerald Health Therapeutics Inc

Start price
Target price
Perf. (%)
€4.12
17.01.18
€7.30
04.06.18
-34.22%
04.06.18

piccolo90 
18.08.19 50%
buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€12.08
03.01.18
€16.00
31.05.18
8.61%
31.05.18

melinda 
18.08.19 50%
sell
AEterna Zentaris Inc.

Start price
Target price
Perf. (%)
€62.92
17.01.18
€40.59
30.05.18
-8.53%
30.05.18

kyron7htx 
22.08.19 50%
buy
Chalice Brands Ltd.

Start price
Target price
Perf. (%)
€4.83
28.11.17
€6.90
28.05.18
-19.05%
28.05.18

melinda 
14.08.19 50%
buy
Chalice Brands Ltd.

Start price
Target price
Perf. (%)
€4.83
28.11.17
€6.90
28.05.18
-19.05%
28.05.18

melinda 
14.08.19 50%
buy
Supreme Cannabis Company Inc

Start price
Target price
Perf. (%)
€1.00
02.05.18
€2.00
23.05.18
23.00%
23.05.18

melinda 
18.08.19 50%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€17.74
27.02.18
€22.00
22.05.18
43.24%
22.05.18

Could be worthwhile Investment >10% per year
melinda 
18.08.19 50%
buy
Theratechnologies Inc.

Start price
Target price
Perf. (%)
€6.48
11.03.18
€8.00
22.05.18
41.98%
22.05.18

melinda 
18.08.19 50%
buy
IntelliPharmaCeutics International Inc.

Start price
Target price
Perf. (%)
€3.07
08.05.18
€5.41
18.05.18
25.00%
18.05.18

melinda 
18.08.19 50%
buy
Trillium Therapeutics

Start price
Target price
Perf. (%)
€8.70
18.11.17
€13.08
18.05.18
-37.82%
18.05.18

melinda 
14.08.19 50%
buy
Bausch Health Companies Inc.

Start price
Target price
Perf. (%)
€13.02
16.11.17
€26.97
16.05.18
53.05%
16.05.18

piccolo90 
18.08.19 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€7.09
06.04.18
€9.00
10.04.18
-15.80%
10.04.18

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Traumtanz 
05.08.19 50%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€5.45
28.06.17
€29.90
05.04.18
219.22%
05.04.18

Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
geldnutzer 
15.08.19 50%
buy
Invictus MD Strategies

Start price
Target price
Perf. (%)
€1.59
24.01.18
€3.10
19.03.18
-23.90%
19.03.18

Maxi_Scalibusa 
15.08.19 50%